[
  {
    "section": "section:1",
    "title": "Abstract"
  },
  {
    "section": "section:1",
    "title": "Introduction"
  },
  {
    "section": "section:1",
    "title": "Materials and Methods"
  },
  {
    "section": "section:2",
    "title": "Eligibility criteria"
  },
  {
    "section": "section:2",
    "title": "Study design and statistical methods"
  },
  {
    "section": "section:2",
    "title": "Drug administration"
  },
  {
    "section": "section:2",
    "title": "Biomarker analyses"
  },
  {
    "section": "section:1",
    "title": "Results"
  },
  {
    "section": "section:2",
    "title": "Patient demographics and disease characteristics"
  },
  {
    "section": "section:2",
    "title": "Safety and drug administration"
  },
  {
    "section": "section:2",
    "title": "Efficacy"
  },
  {
    "section": "section:2",
    "title": "Longer PFS among patients with high baseline plasma NRG1, and low AREG, TGFÎ± and IL6"
  },
  {
    "section": "section:1",
    "title": "Discussion"
  },
  {
    "section": "section:1",
    "title": "Conclusions"
  },
  {
    "section": "section:1",
    "title": "References"
  },
  {
    "section": "section:1",
    "title": "Figure 1"
  },
  {
    "section": "section:1",
    "title": "Figure 2"
  },
  {
    "section": "section:1",
    "title": "Figure 3"
  },
  {
    "section": "section:1",
    "title": "Table 1"
  },
  {
    "section": "section:1",
    "title": "Table 2"
  },
  {
    "section": "section:1",
    "title": "Table 3"
  },
  {
    "section": "section:1",
    "title": "Table 4"
  }
]